nav-left cat-right
cat-right

NIH chief to shift more funds to back the most pro...

NIH Director Francis Collins plans to start off 2014 with a New Year’s resolution to spend more of the institute’s bucks backing the most promising investigators, shifting some money away from the project grants that dominate its approach to backing high-risk early-stage research. Nature picked up on the initiative, reporting that Collins was inspired to back a change in strategy after witnessing the success of...

Venus gets Innovative 100 Award for Elores

Chandigarh, December 23 2013: Venus Remedies Limited, a leading research-based global pharmaceutical company, has received the “Innovative 100 Award” for its novel research product Elores, a drug designed to fight superbugs against which other antibiotics fail to respond, at an award function organized by “Inc India”, a business magazine, in New Delhi. After receiving the award, Mr Pawan Chaudhary, Chairman and...

NIH awarded nine awards for NCATS’ New Therapeutic...

NIH awarded $12.7 million for nine awards for NCATS’ New Therapeutic Uses program which matches academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients. Christopher Austin comments “These awards will support cooperative agreements with nine different academic research groups that are going to conduct pre-clinical validation — clinical feasibility studies...

Kidney cancer research grant a NZ first

Press Release: University of Auckland Media Release Wednesday 16 December 2009 The Auckland Cancer Society Research Centre at The University of Auckland Kidney cancer research grant a NZ first University of Auckland chemist Associate Professor Michael Hay has become the first New Zealand scientist to receive a grant from a leading international charity for funding cancer research. Dr Hay and his team at the...

University of California, San Francisco, Researche...

Bethesda, MD, December 12, 2009 –(PR.com)– James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his pioneering studies in the field of protein engineering. Wells,...

Professor Receives Grant to Develop More Rapid Tec...

AUSTIN, Texas — Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers. Biomarkers are small molecules that indicate the presence of a particular physiological condition, typically a disease. The new method, if successful,...
Page 2 of 912345...Last »